Conor completed his bachelor’s and doctoral studies at University College Dublin, supervised by Prof. Stefan Oscarson, where he applied chemical glycobiology to study Cryptococcus neoformans, a World Health Organization priority fungal pathogen. During his PhD, he was a visiting scholar at the Johns Hopkins Bloomberg School of Public Health.

In 2020, he joined the Max Planck Institute of Colloids and Interfaces as a Marie Skłodowska-Curie Fellow with Prof. Peter Seeberger, combining automated synthesis and chemical biology to study marine glycans. In 2025, he joined the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) as a Walter Benjamin Fellow, developing inhibitors of gut microbiota sulfatases.

His research has been recognised by the Institute of Chemistry of Ireland and the Royal Irish Academy with the Kathleen Lonsdale Chemistry Prize (2021).

In 2026, he started his group at Trinity College Dublin.